Skip to main content

Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine

Johnson & Johnson has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company announced Sunday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.